The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Efficiency of plasma exchange in Guillain‐Barré syndrome: Role of replacement fluids
Abstract
The goals of this multicenter controlled trial were: (1) to study the short‐term effect of plasma exchange in the Guillain‐Barré syndrome when applied alone within 17 days of onset of the disease; and (2) to compare two replacement fluids, diluted albumin and fresh frozen plasma (FFP) with regard to efficacy and morbidity. Two hundred twenty patients were included, 111 in the control group, 109 in the plasma exchange group, 57 of whom were assigned to receive albumin and 52 to receive fresh frozen plasma. Treatment consisted of four plasma exchanges of two plasma volumes each, initiated on the day of randomization and repeated on alternate days. Significant short‐term benefits appeared in the group that received plasma exchange as demonstrated by the reduction in the proportion of patients who required assisted ventilation after randomization, and the decrease in time before beginning weaning from ventilator, time to onset of motor recovery, and time to walk with and without assistance. No statistically significant difference was found between the group that received albumin and the group that received fresh frozen plasma. Incidents during exchanges and complications related to the plasma exchange were more frequent in patients who received fresh frozen plasma. Plasma exchange is beneficial in Guillain‐Barré syndrome when it is carried out early in the course of the disease. Given its risks and the lack of its clear superiority over albumin, however, we recommend that fresh frozen plasma be abandoned in the treatment of Guillain‐Barré syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship
BRESLOW, N. (1970) · Biometrika · doi:10.1093/biomet/57.3.579 · Cited by 1,411
CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHY
Hughes, R. A. C., Newsom-Davis, J. M., Perkin, G. D., & Pierce, J. M. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92644-2 · Cited by 1,123
Plasmapheresis and acute Guillain‐Barre syndrome
The Guillain-Barré Syndrome Study Group (1985) · Neurology · doi:10.1212/wnl.35.8.1096 · Cited by 773
Plasmapheresis and Immunosuppressive Drug Therapy in Myasthenia Gravis
Dau, P. C., Lindstrom, J. M., Cassel, C. K., Denys, E. H., Shev, E. E., & Spitler, L. E. (1977) · New England Journal of Medicine · doi:10.1056/nejm197711242972102 · Cited by 402
Criteria for the diagnosis of the Guillain-Barré syndrome
Poser, C. M. (1981) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(81)90004-6 · Cited by 264
Autonomic dysfunction in the Guillain-Barré syndrome
Lichtenfeld, P. (1971) · The American Journal of Medicine · doi:10.1016/0002-9343(71)90185-9 · Cited by 211
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR MYASTHENIA GRAVIS
Gajdos, P., Outin, H., Elkharrat, D., Brunel, D., de Rohan-Chabot, P., Raphael, J. C., Goulon, M., Goulon-Goeau, C., & Morel, E. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90469-0 · Cited by 195
CONTROLLED TRIAL OF PLASMA EXCHANGE IN ACUTE INFLAMMATORY POLYRADICULONEUROPATHY
Greenwood, R. J., Hughes, R. A. C., Bowden, A. N., Gordon, N. S., Millac, P., Newsom-Davis, J., Aslan, S., Chadwick, D. W., Mclellan, D. L., Stott, R. B., et al. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91341-2 · Cited by 169
TREATMENT OF ACUTE POLYNEUROPATHY BY PLASMA EXCHANGE
Brettle, R. P., Gross, M., Legg, N. J., Lockwood, M., & Pallis, C. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91837-8 · Cited by 163
Demyelination induced by serum form patients with Guillain‐Barré syndrome
Harrison, B. M., Hansen, L. A., Pollard, J., & McLeod, J. G. (1984) · Annals of Neurology · doi:10.1002/ana.410150209 · Cited by 106
Plasma Exchange as a Therapy for Guillain-Barré Syndrome with Immune Complexes
Valbonesi, M., Garelli, S., Mosconi, L., Zerbi, D., & Celano, I. (1981) · Vox Sanguinis · doi:10.1111/j.1423-0410.1981.tb01017.x · Cited by 42
Cited by
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
van der Meché, F. G. A., Schmitz, P. I. M., & the Dutch Guillain–Barré Study Group* (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261705 · Cited by 1,143
Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis
van den Berg, B., Walgaard, C., Drenthen, J., Fokke, C., Jacobs, B. C., & van Doorn, P. A. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.121 · Cited by 1,101
Kleyweg, R. P., Van Der Meché, F. G. A., & Schmitz, P. I. M. (1991) · Muscle & Nerve · doi:10.1002/mus.880141111 · Cited by 926
Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome
van Doorn, P. A., Ruts, L., & Jacobs, B. C. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70215-1 · Cited by 828
Metadata
- Authors
- French Cooperative Group on Plasma Exchange in Guillain‐Barrk Syndrome
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1987-12
- Volume
- 22
- Issue
- 6
- Pages
- 753-761
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W4251253802
- Cited by
- 457
- References
- 12
- FWCI
- 10.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.